Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UnitedHealth GroupUNH -1.74%79 EV-to-EBITDA is 18.49 as of Aug. 06, 2026, which is 29% above its 10-year median of 14.33. GuruFocus rates UNH with a GF Score™ of 79/100 and a GF Value™ of $604.44 (Significantly Undervalued). The stock has 9 warning signs investors should review. Among 15 Healthcare Plans companies, UnitedHealth Group ranks worse than 73.33% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, UnitedHealth Group's enterprise value is $422,453 Mil.
UnitedHealth Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $22,842 Mil. Therefore, UnitedHealth Group's EV-to-EBITDA for today is 18.49.
The historical rank and industry rank for UnitedHealth Group's EV-to-EBITDA or its related term are showing as below:
UNH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.83 Med: 14.33 Max: 22.34
Current: 18.49
During the past 13 years, the highest EV-to-EBITDA of UnitedHealth Group was 22.34. The lowest was 7.83. And the median was 14.33.
UNH's EV-to-EBITDA is ranked worse than 73.33% of 15
companies
in the Healthcare Plans industry
Industry Median: 14.08
vs UNH: 18.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
UnitedHealth Group (NYSE:UNH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
UnitedHealth Group's PE Ratio (TTM) for today is calculated as:
UnitedHealth Group's share price for today is $405.5825.
UnitedHealth Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for UnitedHealth Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, UnitedHealth Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UnitedHealth Group EV-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, UnitedHealth Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where UnitedHealth Group's EV-to-EBITDA falls into.
UnitedHealth Group's current Enterprise Value is $422,453 Mil.
UnitedHealth Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22,842 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UnitedHealth Group (UNH) has a EV-to-EBITDA of 18.49 as of Aug. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on UnitedHealth Group. This is 29% above median its historical median of 14.33. Over the past decade, UnitedHealth Group's EV-to-EBITDA has ranged from 7.83 to 22.34. According to the industry distribution chart, UnitedHealth Group ranks #11 out of 15 companies in the Healthcare Plans industry, placing it in the top 73.3%.
Is UnitedHealth Group's EV-to-EBITDA too high?
UnitedHealth Group's current EV-to-EBITDA of 18.49 is 29% above median its 10-year median of 14.33. Over the past 10 years, this metric has ranged from a low of 7.83 to a high of 22.34. The Healthcare Plans industry median EV-to-EBITDA is 14.08. UnitedHealth Group's value of 18.49 is 31.3% above this industry median. Based on the distribution chart, UnitedHealth Group ranks #11 out of 15 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, UnitedHealth Group has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's EV-to-EBITDA compare to CVS and ELV?
According to the Healthcare Plans industry distribution chart, UnitedHealth Group ranks #11 out of 15 companies for EV-to-EBITDA. This places UnitedHealth Group in the lower half of its industry. The industry median EV-to-EBITDA is 14.08. UnitedHealth Group's value of 18.49 is 31.3% above this benchmark. Historically, UnitedHealth Group's own EV-to-EBITDA has ranged from 7.83 to 22.34 over the past decade. While the company's 10-year median is 14.33 vs. the industry median of 14.08, UnitedHealth Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Plans company?
The median EV-to-EBITDA among Healthcare Plans companies is 14.08, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UnitedHealth Group's current EV-to-EBITDA of 18.49 is 31.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on UnitedHealth Group. For the Healthcare Plans industry, the median EV-to-EBITDA is 14.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UnitedHealth Group's current EV-to-EBITDA is 18.49, which is 29% above median its own 10-year median of 14.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
Based on GuruFocus' analysis, UnitedHealth Group (UNH) is currently considered Significantly Undervalued. The stock's GF Value™ is $604.44, compared to a current price of $405.58 — trading 32.9% below its estimated fair value. The current EV-to-EBITDA is 18.49, which is 29% above median its 10-year median of 14.33 and 31.3% above the Healthcare Plans industry median of 14.08. UnitedHealth Group's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For UnitedHealth Group (UNH), the current EV-to-EBITDA is 18.49 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UnitedHealth Group (UNH) Overvalued in 2026?
Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued.
The current stock price of $405.58 is trading 32.9% below its estimated GF Value™ of $604.44.
GuruFocus considers UnitedHealth Group to be Significantly Undervalued.
Key valuation signals for UNH:
EV-to-EBITDA: 18.49 (29% above median its 10-year median of 14.33)
GF Value™: $604.44 vs. price of $405.58 (32.9% below fair value)
Industry Position: 31.3% above the Healthcare Plans median (#11 of 15)
No single metric tells the full story. See the UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
79GF Score
Get the complete analysis for UNH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNH has been successfully added to your 
